UK markets close in 5 hours 39 minutes

SpineGuard SA (ALSGD.PA)

Paris - Paris Delayed price. Currency in EUR
Add to watchlist
0.9215+0.0045 (+0.49%)
As of 11:34AM CEST. Market open.
Full screen
Previous close0.9170
Open0.9170
Bid0.0000 x 0
Ask0.0000 x 0
Day's range0.8865 - 0.9295
52-week range0.7560 - 1.8700
Volume7,461
Avg. volume212,543
Market cap27.381M
Beta (5Y monthly)3.00
PE ratio (TTM)N/A
EPS (TTM)-0.0910
Earnings date29 Apr 2022
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est1.70
  • Business Wire

    SpineGuard's DSG® Technology Applied to Robotics: Three Scientific Articles Presented at the Conference on New Technologies for Computer and Robot Assisted Surgery (CRAS)

    PARIS & BOULDER, Colo., May 04, 2022--Regulatory News: SpineGuard (FR0011464452 – ALSGD), an innovative company that deploys its DSG® (Dynamic Surgical Guidance) sensing technology to secure and streamline the placement of bone implants, announced that research teams presented three articles at the CRAS conference on April 25th and 26th in Naples, Italy. They report the progress made with the robotic application of DSG.

  • Business Wire

    Annual Shareholders’ Meeting SpineGuard June 8, 2022

    PARIS & BOULDER, Colo., May 02, 2022--Regulatory News: SpineGuard (Paris:ALSGD) (FR0011464452 – ALSGD), an innovative company that deploys its DSG® (Dynamic Surgical Guidance) sensing technology to secure and streamline the placement of bone implants, announces that its Annual Shareholders’ Meeting will be held on Wednesday June 8, 2022 at 10:00am CEST at the offices of the law firm Ashurst located in Paris, at 18, Square Edouard VII, 75009 (France) and inform on its voting modalities.

  • Business Wire

    SpineGuard Announces Its Full-Year 2021 Financial Results and Its First Quarter 2022 Sales

    PARIS & BOULDER, Colo., April 28, 2022--Regulatory News: SpineGuard (FR0011464452 – ALSGD) (Paris:ALSGD), an innovative company that deploys its DSG (Dynamic Surgical Guidance) sensing technology to secure and streamline the placement of bone implants, announced today its full-year 2021 financial results, as approved by the Board of Directors on April 28, 2022 and its first quarter 2022 sales.